3-year follow-up of a phase III study comparing SB3 (trastuzumab biosimilar) and reference trastuzumab in HER2 positive early or locally advanced breast cancer in neoadjuvant setting. (March 2019)

Record Type:
Journal Article
Title:
3-year follow-up of a phase III study comparing SB3 (trastuzumab biosimilar) and reference trastuzumab in HER2 positive early or locally advanced breast cancer in neoadjuvant setting. (March 2019)
Main Title:
3-year follow-up of a phase III study comparing SB3 (trastuzumab biosimilar) and reference trastuzumab in HER2 positive early or locally advanced breast cancer in neoadjuvant setting
Authors:
Pivot, X.
Bondarenko, I.
Dvorkin, M.
Sarosiek, T.
Wojtukiewicz, M.
Shparyk, Y.
Kim, Y.
Lim, J.
Abstract:
Is Part Of:
Breast. Volume 44(2019)Supplement 1
Journal:
Breast
Issue:
Volume 44(2019)Supplement 1
Issue Display:
Volume 44, Issue 2019 (2019)
Year:
2019
Volume:
44
Issue:
2019
Issue Sort Value:
2019-0044-2019-0000
Page Start:
S68
Page End:
Publication Date:
2019-03
Subjects:
Breast -- Diseases -- Periodicals
Breast -- Tumors -- Periodicals
Breast -- Periodicals
Electronic journals
Periodicals
616
Journal URLs:
http://www.sciencedirect.com/science/journal/09609776 ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0960-9776;screen=info;ECOIP ↗
http://www.harcourt-international.com/journals/brst/ ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09609776 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09609776 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/S0960-9776(19)30257-7 ↗
Languages:
English
ISSNs:
0960-9776
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 2277.492700
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:
9969.xml